Announcement: From January 2021Complementary Therapies in Medicine will become an open access journal. Authors who publish in Complementary Therapies in Medicine will be able to make their work immediately, permanently, and freely accessible.
Complementary Therapies in Medicine continues with the same aims and scope, editorial team, submission system and rigorous peer review.
Complementary Therapies in Medicine authors will pay an article publishing charge (APC), have a choice of license options, and retain copyright to their published work. The APC will be requested after peer review and acceptance. The APC payment will be required for all accepted articles submitted after the 30th of September 2020. The APC for Complementary Therapies in Medicine will be USD 1800 (excluding taxes).
Please note: Authors who have submitted their paper on or before the 30th of September 2020, will have their accepted article published in Complementary Therapies in Medicine at no charge. Authors submitting their paper after this date will be requested to pay the APC. For more details visit our FAQs page.
Complementary Therapies in Medicine is an international, peer-reviewed journal that has considerable appeal to anyone who seeks objective and critical information on complementary therapies or who wishes to deepen their understanding of these approaches. It will be of particular interest to healthcare practitioners including family practitioners, complementary therapists, nurses, and physiotherapists; to academics including social scientists and CAM researchers; to healthcare managers; and to patients.
Complementary Therapies in Medicine aims to publish valid, relevant and rigorous research and serious discussion articles with the main purpose of improving healthcare. The journal believes that good healthcare needs to be based on clinical judgement and the available evidence on what is safe and effective, integrating conventional and complementary therapies as appropriate.
Complementary Therapies in Medicine focuses on prospectively registered human randomized controlled trials using CONSORT criteria and systematic reviews, registered in PROSPERO, that follow 2020 PRISMA guidelines. We do not consider study protocols, animal or in vitro research, network pharmacology, or case reports/series. We occasionally consider observational studies using STROBE guidelines; and we consider pilot studies focusing on feasibility of recruitment/retention/blinding/fidelity to study protocols.
Each issue features original, high quality research on complementary medicine, as well as information and experiences on integrating complementary medicine into mainstream care.
Announcement: From January 2021Complementary Therapies in Medicine will become an open access journal. Authors who publish in Complementary Therapies in Medicine will be able to make their work immediately, permanently, and freely accessible.
Complementary Therapies in Medicine continues with the …
